Bio-Rad Laboratories Inc
Закрыт
СекторЗдравоохранение
278.8 2.85
Обзор
Изменение цены акций
24 ч
Мин.
269.92
Макс.
283.35
Доход | -731M -11M |
|---|---|
Продажи | -101M 592M |
P/E Средняя по отрасли | 46.696 50.958 |
Прибыль на акцию | 1.89 |
Рентабельность продаж | -1.858 |
Сотрудники | 7,450 |
EBITDA | -751M -637M |
Рекомендации | Нейтрально |
|---|---|
Прогноз на 12 месяцев | +11.44% upside |
Следующий отчет о доходах | 30 июл. 2026 г. |
|---|
Рыночная капитализация | -235M 7.5B |
|---|---|
Предыдущая цена открытия | 275.95 |
Предыдущая цена закрытия | 278.8 |
Новостные настроения
By Acuity
50%
50%
146 / 342 Рейтинг в Healthcare
Bio-Rad Laboratories Inc График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.